OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.

PubMed

Year: 1998
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: R J Motzer, A Rakhit, L H Schwartz, T Olencki, T M Malone, K Sandstrom, R Nadeau, H Parmar, R Bukowski
Institution: Memorial Sloan Kettering Cancer Center
Language: English

Topic: Renal cell carcinoma treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: renal cell carcinoma, subcutaneous administration, maximum tolerated dose, dose-limiting toxicity, cytokine therapy, interferon-gamma, transaminase elevation, leukopenia, pulmonary toxicity, antitumor immunity, advanced cancer treatment, phase I trial design, dose escalation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1502100938
FWCI: 8.883
Cites:
Cited by: 251
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms